… receptor (EGFR) and vascular endothelial growth factor (VEGF), … of EGFR and HER-2, has
been approved to treat HER-2-… to mRNA through pairing, thereby inhibiting the expression …

… EGFR is overexpressed in most esophageal cancers and the … in drug resistance in the HER-2
IHC2 + /PIK3CA mutation … , use of antibodies against EGFR or VEGF ligands and oral TKIs …

… that among 10 ESCC patients, mRNA expression of CD22 in … are rare but have included
EGFR, VEGF, HER-2 and PD-L1 [17, … Based on the relationship between CD22 expression and …

… significant reduction in the mRNA expression level of CSC genes … -1 expression on EGFR
and HER-2 was different between breast … The NSCLC is further subdivided into squamous cell …

… (HER-2), vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR…
in pancreatic ductal adenocarcinoma and esophageal squamous cell carcinoma (15). E2F1 …

… Lapatinib, a small-molecule inhibitor of EGFR and HER-2, … and survival by targeting mRNAs
for cleavage or translational … esophageal squamous cell carcinoma using Fluorescence in …

… of esophageal cancer for known targets like EGFR and HER-2 … compared the expression
levels of CRABP2 mRNA in 286 … , and reduce the expression of ERK/VEGF pathway-related …

… We downloaded the mRNA expression … (EGFR) and vascular endothelial growth factor
(VEGF), respectively. Trastuzumab, an anti-human epidermal growth factor receptor 2 (HER-2) …

… EGFR), human epidermal growth factor receptor 2 (HER-2), or vascular endothelial growth
factor (VEGF… ) and the prognostic value of C1R mRNA was assessed using the Survfit function …

… Moreover, EGFR-, HER-2-, or VEGF-targeted therapy does … Several studies have
established a link between CAFs and … They found that hsa-miR-3656 mRNA expression was …